Charles Bonnet syndrome: two case reports and review of the literature

被引:0
|
作者
Alberto Lerario
Andrea Ciammola
Barbara Poletti
Floriano Girotti
Vincenzo Silani
机构
[1] IRCCS Istituto Auxologico Italiano,Department of Neurology and Laboratory of Neuroscience
[2] Università degli Studi di Milano,Dipartimento di Fisiopatologia Medico
来源
Journal of Neurology | 2013年 / 260卷
关键词
Visual hallucinations; Age related macular degenerations; Eye diseases; Visual pathway; Visual loss; Extrapyramidal syndromes;
D O I
暂无
中图分类号
学科分类号
摘要
Visual hallucinations (VHs) can be associated with a variety of clinical conditions, and are also experienced by healthy people due to visual impairment. The condition is known as Charles Bonnet Syndrome (CBS). The circumstances favoring VHs support the hypothesis that sensory deprivation enhances the ongoing activity of the visual system after sensory loss. Clinician should be aware that a significant proportion of visually impaired patients experience complex VHs, which are sometimes distressing. Herein, we report two cases of CBS. Case 1 is a 60-year-old man with visual impairment due to orbit pseudotumor in autoimmune hypothyroidism. Case 2 is an 87-year-old woman with Parkinson’s disease and a 15-year history of intermittent complex VHs due to age-related macular degeneration in both eyes. In both cases investigations for alternative pathological causes of VHs were negative and, therefore, the aetiology of hallucinations was attributed to CBS. The course and treatment of CBS patients vary according to the nature of the visual dysfunction. Drug treatments remain partially satisfactory, with individual cases successfully treated with atypical antipsychotics. Nonpharmacological interventions aimed to reduce the visual pathway deprivation. Reassurance of the benign nature of CBS is essential to support patients and reduce caregiver’s burden.
引用
收藏
页码:1180 / 1186
页数:6
相关论文
共 50 条
  • [31] Atypical Charles Bonnet syndrome secondary to frontal meningioma: a case report
    Lomelín-López Diana
    Jaime Carmona-Huerta
    J. Guillermo Patiño
    Aldana-López Alejandro
    Durand-Arias Sol
    BMC Psychiatry, 21
  • [32] Negative outcome Charles Bonnet Syndrome
    Cox, Thomas M.
    Ffytche, Dominic H.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (09) : 1236 - 1239
  • [33] Atypical Charles Bonnet syndrome secondary to frontal meningioma: a case report
    Diana, Lomelin-Lopez
    Carmona-Huerta, Jaime
    Patino, J. Guillermo
    Alejandro, Aldana-Lopez
    Sol, Durand-Arias
    BMC PSYCHIATRY, 2021, 21 (01)
  • [34] Charles Bonnet Syndrome disappearing with carbamazepine and valproic acid but not with levetiracetam
    Segers, Kurt
    ACTA NEUROLOGICA BELGICA, 2009, 109 (01) : 42 - 43
  • [35] Charles Bonnet Syndrome as a Manifestation of Leptomeningeal Metastases
    Rashid, Anis
    Valentine, Alan D.
    PSYCHOSOMATICS, 2010, 51 (05) : 447 - 447
  • [36] Charles Bonnet, his life, and his syndrome
    Hedges, Thomas R., Jr.
    SURVEY OF OPHTHALMOLOGY, 2007, 52 (01) : 111 - 114
  • [37] Seeing the unseen: Charles Bonnet syndrome revisited
    Nair, Aditya Gopinathan
    Nair, Akshay Gopinathan
    Shah, Bharat R.
    Gandhi, Rashmin Anilkumar
    PSYCHOGERIATRICS, 2015, 15 (03) : 204 - 208
  • [38] Family physician awareness of Charles Bonnet syndrome
    Gordon, Keith D.
    Felfeli, Tina
    FAMILY PRACTICE, 2018, 35 (05) : 595 - 598
  • [39] Charles Bonnet syndrome with peripheral and central findings
    Fernandez, A
    Lichtshein, G
    Vieweg, WVR
    Winfrey, CJ
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1996, 11 (09) : 773 - 778
  • [40] Charles Bonnet syndrome secondary to panretinal photocoagulation
    Santos-Bueso, E.
    Serrador-Garcia, M.
    Saenz-Frances, F.
    Garcia-Sanchez, J.
    NEUROLOGIA, 2015, 30 (05): : 322 - 323